ST
ANIP icon

Spot Trading’s ANI Pharmaceuticals ANIP Stock Holding History

Spot Trading’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,700
Closed -$95K – 3040
2016
Q2 		$95K Buy
1,700
+200
+13% +$9.72K ﹤0.01% 2547
2016
Q1 		$50K Buy
+1,500
New +$50.9K ﹤0.01% 2806

Other funds holding ANIP

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Spot Trading's ANIP Position: Q1 2016 in Review

Spot Trading sold out of ANI Pharmaceuticals (ANIP) in Q1 2016, closing a stake of 160 shares — an estimated $5.43K sold.

Spot Trading first reported a position in ANIP in Q3 2015 and held it in 2 quarters. The position peaked at $63K in Q3 2015. 121 funds tracked by Wall St. Rank hold ANIP as of Q1 2016.

  • Spot Trading reported no remaining ANI Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Spot Trading sold 160 ANI Pharmaceuticals shares in Q1 2016, an estimated $5.43K.
  • Spot Trading first reported a position in ANI Pharmaceuticals in Q3 2015 and held it in 2 quarters.
  • Spot Trading's ANI Pharmaceuticals position peaked at $63K in Q3 2015.
  • 121 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2016.

Based on Spot Trading's 13F filing for Q1 2016, filed 10 May 2016.